Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by longondmxon Nov 09, 2006 9:18am
391 Views
Post# 11647054

Cash position is okay

Cash position is okayBased on my calculations, Nuvo has enough cash for at least the next 8 months - well after FDA decision is expected. It looks like their burn rate was about $1MM per month...but this should be much less now or should be coming down soon since they should not have the expenses associated to preparing/dealing with the FDA re-submission that they had for the last few quarters. Looking forward to better days ahead. I suspect FDA decision will come much sooner than December 28th. Probably a couple of weeks sooner, well before the Xmas season kicks in to full gear. With the support and comments from Nuvo FDA advisors saying that FDA approval is likely based on the latest positive Phase III results and that it meets all FDA conditions that were listed in their non-approval letter, I'd say this is a great gamble..one that is equivalent to betting on the temperature on Xmas day to be below 30 degrees celcius in Ontario. The possibility exists that is will be 30 degrees or higher, but it is very very unlikely.
Bullboard Posts